1. Home
  2. NSPR vs GNS Comparison

NSPR vs GNS Comparison

Compare NSPR & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.73

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Logo Genius Group Limited

GNS

Genius Group Limited

BUY

Current Price

$0.10

Market Cap

32.1M

Sector

Real Estate

ML Signal

BUY

Company Overview

Basic Information
Metric
NSPR
GNS
Founded
2005
2002
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
32.1M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NSPR
GNS
Price
$0.73
$0.10
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
336.1K
★ 2.5M
Earning Date
11-12-2026
09-28-2026
Dividend Yield
N/A
★ 197.24%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
$127.02
Revenue Next Year
$105.44
$36.19
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.43
$0.09
52 Week High
$2.22
$1.06

Technical Indicators

Market Signals
Indicator
NSPR
GNS
Relative Strength Index (RSI) 59.13 29.72
Support Level $0.66 N/A
Resistance Level $0.77 $0.14
Average True Range (ATR) 0.10 0.01
MACD 0.04 -0.00
Stochastic Oscillator 74.86 25.13

Price Performance

Historical Comparison
NSPR
GNS

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.

Share on Social Networks: